Stanford University - Stanford Cancer Institute — Stanford, California

Stanford University - Stanford Cancer Institute is a clinical research site located in Stanford, California, United States 94305.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford University - Stanford Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer.

Sponsors: Revolution Medicines, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford University - Stanford Cancer Institute?

Stanford University - Stanford Cancer Institute has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford University - Stanford Cancer Institute conducted?

Stanford University - Stanford Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer.

Is Stanford University - Stanford Cancer Institute accredited by Crixeo Health?

Stanford University - Stanford Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford University - Stanford Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.